Alembic Pharma to raise product filings for US: Report

10 Oct 2016 Evaluate

Alembic Pharmaceuticals is reportedly planning to increase its annual product filings for regulated markets from 7 now to 30 within two years. The Vadodara-based company has increased the number of its projects for product development from 40 in 2013-14 to 200 now. The projects are largely to develop products in injectables and dermatology. These include its own, partnered, and in-licensed products.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.

Alembic Pharma Share Price

870.25 5.50 (0.64%)
16-Dec-2025 10:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1781.00
Dr. Reddys Lab 1274.60
Cipla 1502.10
Zydus Lifesciences 923.90
Lupin 2089.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×